Ashland Inc. (ASH)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 2,016 | 2,111 | 2,391 | 2,191 | 2,113 | 1,824 | 1,843 | 1,866 |
| Operating profit | $m | -775 | - | ||||||
| Net profit | $m | -508 | 220 | 927 | 178 | 169 | -845 | - | 161 |
| EPS reported | $ | -18.37 | 1.13 | ||||||
| Operating cashflow per share | $ | 2.04 | 8.57 | ||||||
| Capex per share | $ | 2.13 | 1.54 | ||||||
| FCF per share | $ | -0.09 | 7.02 | ||||||
| Free cash flow | $m | -4 | 323 | ||||||
| Net debt | $m | 1,275 | 934 | ||||||
| Book value equity | $m | 1,904 | 1,870 | ||||||
| Book value per share | $ | 41.39 | 40.65 | ||||||
| Number of shares | m | 46 | 46 | ||||||
| DPS (TTM paid) | $ | 1.65 | 1.67 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | 61.12 | ||||||
| P/B LTM | x | 1.16 | 1.18 | ||||||
| P/S LTM | x | 1.21 | 1.20 | ||||||
| P/FCF LTM | x | -550.97 | 6.82 | ||||||
| EV/EBITDA LTM | x | -7.00 | 9.14 | ||||||
| EV/Sales LTM | x | 1.95 | 2.37 | ||||||
| Earnings Yield LTM | % | -38.34% | +1.64% | ||||||
| FCF Yield | % | -0.18% | +14.66% | ||||||
| Quality | |||||||||
| ROE | % | -44.38% | +2.77% | ||||||
| ROIC | % | -18.41% | +1.94% | ||||||
| Operating margin | % | -42.49% | +7.33% | ||||||
| Gross margin | % | +30.10% | +29.35% | ||||||
| FCF/Sales | % | -0.22% | +17.53% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -13.68% | -12.78% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | - | +17.88% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | +3.45% | +2.29% | ||||||
| Dividend Growth | % | +3.12% | +4.37% | ||||||
| Payout Ratio | % | -8.99% | +146.21% | ||||||
| FCF/Debt | x | -0.00 | 0.22 | ||||||
| Net Debt/EBITDA | x | -2.67 | 2.66 | ||||||
| EBIT/Net interest | x | -12.30 | 2.21 | ||||||
| Net debt/market cap | % | +67.61% | +41.14% | ||||||
| Net debt/Equity | x | 0.67 | 0.50 | ||||||
| Gross debt/equity | x | 0.83 | 0.79 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Ashland Inc. operates as a global supplier of specialized chemicals and additives. Its business activities are structured into four main divisions: Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents. The Life Sciences segment delivers pharmaceutical formulations, encompassing controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and binding agents for tablets. It also offers nutritional compounds like thickeners, stabilizers, emulsifiers, and various additives, alongside nutraceutical items designed for weight management, joint comfort, gastrointestinal health, sports nutrition, and general well-being. Additionally, this division provides custom formulation services, toll processing, and particle engineering expertise. The Personal Care & Household division manufactures a diverse array of naturally derived, biodegradable, and high-performance ingredients for personal care products. Its offerings extend to solutions for oral hygiene, such as toothpastes, mouthwashes, denture cleansers, and general dental care. For household applications, it supplies nature-sourced rheology modifiers, biodegradable wetting agents for surfaces, advanced encapsulants, and specialized polymers. The Specialty Additives segment's portfolio includes rheology modifiers, agents for foam control, surfactants, wetting agents, pH neutralizers, and advanced ceramic materials, which find application in catalytic converters, environmental filters, components for ceramic capacitors, plasma display panels, and solar cells. Furthermore, it supplies ingredients for textile printing, thermoplastic metals, and alloys utilized in welding processes. The Intermediates and Solvents division is responsible for producing 1,4 butanediol and its associated derivatives, notably n-methylpyrrolidone. Ashland's diverse product portfolio serves clientele across numerous consumer and industrial sectors, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceuticals. The company, previously known as Ashland Global Holdings Inc., was established in Wilmington, Delaware, in 1924.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free